- Home
- MRK vs SAN Comparison
MRK vs SAN Comparison
Compare MRK & SAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | SAN |
|---|---|---|
| Founded | 2000 | 1857 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 201.7B |
| IPO Year | 1995 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MRK | SAN |
|---|---|---|
| Price | $135.95 | $14.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 1 |
| Target Price | ★ $125.59 | N/A |
| AVG Volume (30 Days) | 5.9M | ★ 12.0M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.06% | 1.54% |
| EPS Growth | ★ 8.01 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.61 | $34.53 |
| Revenue Next Year | $5.41 | $6.55 |
| P/E Ratio | ★ N/A | $11.21 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $77.58 | $9.31 |
| 52 Week High | $135.97 | $15.00 |
Technical Indicators
Market Signals| Indicator | MRK | SAN |
|---|---|---|
| Relative Strength Index (RSI) | 70.00 | 62.02 |
| Support Level | $112.68 | $11.75 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 3.23 | 0.22 |
| MACD | 0.55 | 0.02 |
| Stochastic Oscillator | 98.08 | 81.40 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About SAN Banco Santander S.A. Sponsored ADR (Spain)
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.